-
Martin's Point Health Care Named One of the 2019 Best Workplaces in Health Care and Biopharma
Post on 4/14/19
-
X4 Pharmaceuticals Prices $85.8M Public Offering of Common Stock
Post on 4/14/19
-
Peak Physical Therapy & Sports Performance Appoints Donna Chiao as Staff Physical Therapist
Post on 4/14/19
-
TransMedics Group Files For U.S. IPO
Post on 4/12/19
-
Cara Therapeutics: Targeting CKD-Associated Pruritus
Post on 4/12/19
-
Trevi Therapeutics Begins IPO Process
Post on 4/12/19
-
bluebird bio's CHMP Response Lays Groundwork For Its First Gene Therapy Approval
Post on 4/12/19
-
Summit Health Management Partners with Arcadia.io
Post on 4/11/19
-
X4 Pharmaceuticals Proposes Public Offering of Common Stock
Post on 4/11/19
-
Intrinsic Therapeutics Completes $52M Financing
Post on 4/11/19
-
Sonde Completes $16 Million Series A Financing
Post on 4/11/19
-
AskBio Lands $235M Financing From TPG And Vida Ventures
Post on 4/11/19
-
Provident Healthcare Partners Advises Southeast Gastro In Its Partnership With Gastro Health
Post on 4/10/19
-
Curis Regains Compliance with Nasdaq Continued Listing Requirements
Post on 4/10/19
-
Inozyme Pharma Raises $67 Million in Series A2 Financing
Post on 4/10/19
-
Why bluebird bio Could Deliver Miracles to Genetic Disease Patients
Post on 4/10/19
-
Biogen Alzheimer's Failure Is Not Surprising, More Will Follow
Post on 4/10/19
-
Berkshire Hathaway's True Moat
Post on 4/10/19
-
Why Vertex Pharmaceuticals Could Conceivably Succeed Too Well
Post on 4/10/19
-
Syros Closes Concurrent Public Offerings
Post on 4/9/19
-
Homology Medicines Prices Public Offering of Common Stock
Post on 4/9/19
-
AquaBounty Technologies Closes Public Offering of Common Stock
Post on 4/9/19
-
Diameter Health Announces $9.6 Million in Series A-1 Funding Round
Post on 4/9/19
-
Vifor Pharma and Akebia Therapeutics Announce Expansion of License Agreement
Post on 4/9/19
-
Charles River Laboratories and CHDI Foundation Extend Huntington’s Disease Collaboration
Post on 4/9/19